KELLY BETSINGER: Open Payments
NPI 1396202685 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,620 in 13 payments from 10 companies in 2025. Trend: 2023 $358 · 2024 $1,430 · 2025 $1,620
Food & beverage: $1,620
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $285 |
| ABIOMED | 2 | $268 |
| ACADIA Pharmaceuticals Inc | 2 | $236 |
| Abbott Laboratories | 1 | $136 |
| Alkermes, Inc. | 1 | $130 |
| Neurocrine BioSciences, Inc. | 1 | $123 |
| KYOWA KIRIN, INC. | 1 | $121 |
| Radius Health, Inc. | 1 | $117 |
| Amarin Pharma, Inc. | 1 | $113 |
| SI-BONE, INC. | 1 | $92 |
Products named: AMS 700, WATCHMAN FLX, FREESTYLE LIBRE 3, LYBALVI, INGREZZA, DAYBUE, CRYSVITA, Tymlos.
Industry payments across MD — which companies pay providers there.
